Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis

Helping Patients Make Better Personal Health Decisions

(2011) Michael J. Barry   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009

(2010) S. Lee et al.   OSTEOPOROSIS INTERNATIONAL

Patient preferences for osteoporosis in Spain: a discrete choice experiment

(2010) J. Darbà et al.   OSTEOPOROSIS INTERNATIONAL

Racial and ethnic disparities in cardiovascular medication use among older adults in the United States

(2010) Dima M. Qato et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Understanding why rheumatoid arthritis patient treatment preferences differ by race

(2009) Florina Constantinescu et al.   ARTHRITIS AND RHEUMATISM

Racial Disparities in Treatment Preferences for Rheumatoid Arthritis

(2009) Florina Constantinescu et al.   MEDICAL CARE

Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment

(2009) Esther W. de Bekker-Grob et al.   PHARMACOECONOMICS